Todd Deavens
Family Medicine · Atlanta, GANPI 1467749176
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.5% of the total across 152 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 31 manufacturers, the largest accounting for just 12.4% — the pattern of someone who eats at a lot of different presentations.
Across 152 payments — averaging $17.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$339
- Amgen$314
- Lilly USA, LLC$289
- AstraZeneca$260
- Bayer$216
- AbbVie$151
- plus $1K from 25 others
What the payments were for
- Food & beverage$2,63597%
- Education$953%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 22 | $339 |
| Amgen | 17 | $314 |
| Lilly USA, LLC | 21 | $289 |
| AstraZeneca | 15 | $260 |
| Bayer | 6 | $216 |
| AbbVie | 8 | $151 |
| Astellas Pharma US Inc | 4 | $150 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 7 | $108 |
| Otsuka America Pharmaceutical, Inc. | 5 | $100 |
| Merck | 6 | $86 |
| Boehringer Ingelheim | 5 | $85 |
| Pfizer | 5 | $77 |
| Novartis | 3 | $72 |
| GSK | 5 | $72 |
| Sanofi-aventis U.S. LLC | 3 | $69 |
| Shield Therapeutics Inc | 2 | $46 |
| Genentech USA, Inc. | 3 | $40 |
| Dexcom, Inc. | 2 | $32 |
| Mayne Pharma Commercial LLC | 1 | $31 |
| Corcept Therapeutics | 1 | $23 |
| Idorsia Pharmaceuticals US Inc | 1 | $19 |
| Mylan Specialty L.p. | 1 | $19 |
| Inogen, Inc. | 1 | $19 |
| Kowa Pharmaceuticals America, Inc. | 1 | $17 |
| Avanir Pharmaceuticals, Inc. | 1 | $16 |
| Roche Diabetes Care, Inc. | 1 | $16 |
| Nestle Healthcare Nutrition Inc. | 1 | $15 |
| Arbor Pharmaceuticals, Inc. | 1 | $14 |
| Bigfoot Biomedical Inc | 1 | $13 |
| Sunovion Pharmaceuticals Inc. | 1 | $11 |
| Teva Pharmaceuticals USA, Inc. | 1 | $11 |
How this compares
$2,730 in reported general payments places this provider in the 75th percentile of 3,111 family medicine providers in Georgia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 115 | $132,162 |
| EliquisApixaban | 26 | $32,453 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 145 | $22,626 |
| TrulicityDulaglutide | 17 | $18,013 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 17 | $17,847 |
| LinzessLinaclotide | 12 | $15,052 |
| EntrestoSacubitril/Valsartan | 14 | $11,501 |
| JanuviaSitagliptin Phosphate | 11 | $9,838 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 245 | $8,618 |
| Diclofenac Sodium | 126 | $2,394 |
| Atorvastatin Calcium | 339 | $2,016 |
| Wixela InhubFluticasone Propion/Salmeterol | 11 | $1,955 |
| Fluticasone Propionate | 184 | $1,881 |
| Gabapentin | 202 | $1,696 |
| Losartan Potassium | 182 | $1,544 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $339 | $132,162115 claims |
| PfizerEliquis | $77 | $32,45326 claims |
| Lilly USA, LLCTrulicity | $289 | $18,01317 claims |
| GSKTrelegy Ellipta | $72 | $17,84717 claims |
| AbbVieLinzess | $151 | $15,05212 claims |
| NovartisEntresto | $72 | $11,50114 claims |
| MerckJanuvia | $86 | $9,83811 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 3,111 family medicine providers in Georgia.
Other family medicine in Atlanta
- Contessa MetcalfeAtlanta$157K
- Mark TannerAtlanta$94K
- Zazi NylanderAtlanta$35K
- Zia AbdiAtlanta$27K
- Donell CollinsAtlanta$19K
- Lauren PowellAtlanta$16K
- Jeffrey KingsleyColumbus$404K
- Debbie HaginsSavannah$279K
- Yolanda WadeTyrone$233K
- Julian HutchinsWarrenton$222K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.